Alnylam named a top biopharma employer by science magazine

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, today announced that, for the second year in a row, science magazine has named the company a top employer in its annual survey of the biotech and pharmaceutical industry. “we are thrilled to be named a top employer by science for the second year in a row, as we continue to build a top-tier, independent biopharmaceutical company founded on rnai,” said john maraganore, ph.d., ch
ALNY Ratings Summary
ALNY Quant Ranking